Codes / ICD10CM / T42.6X6

T42.6X6 Underdosing of other antiepileptic and sedative-hypnotic drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

Underdosing of other antiepileptic and sedative-hypnotic drugs
ICD-10 Code: T42.6X6

Summary

This code applies to clinical scenarios where other antiepileptic and sedative-hypnotic drugs are administered at subtherapeutic levels, leading to insufficient therapeutic effect. It includes cases of underdosing due to incorrect dosing, patient non-compliance, or pharmacokinetic factors that reduce drug efficacy. The classification focuses on the insufficient drug exposure and its impact on the underlying condition.

Causes

Underdosing may result from subtherapeutic dosing, patient failure to adhere to prescribed regimens, or altered drug metabolism affecting absorption or clearance. It can occur due to medication errors, improper administration, or factors like malabsorption. Intentional underdosing for self-harm is not included here.

Risk Factors

  • Polypharmacy increasing dosing complexity.
  • History of epilepsy, sleep disorders, or other conditions treated with these drugs.
  • Age-related changes affecting drug metabolism or compliance.
  • Limited supervision or access to medications.
  • Cognitive impairment or memory issues impacting adherence.

Symptoms

  • Recurrence of underlying condition symptoms (e.g., seizures, insomnia).
  • Reduced therapeutic effect of the medication.
  • Worsening of condition-specific symptoms despite treatment.

Diagnosis

Diagnosis involves assessing clinical presentation, medication history, and therapeutic drug levels. Healthcare providers evaluate adherence, dosing accuracy, and potential pharmacokinetic factors. Clinical judgment determines if symptoms stem from underdosing rather than other causes.

Treatment Options

Treatment focuses on optimizing dosing, improving adherence, or adjusting therapy. This may include dose increases, alternative formulations, or addressing barriers to compliance. Underlying conditions are managed based on clinical needs.

Prognosis and Follow-Up

Prognosis depends on the underlying condition and timely correction of underdosing. Follow-up ensures therapeutic levels are achieved and maintained. Regular monitoring of symptoms and drug levels may be necessary.

Complications

Complications include uncontrolled seizures, persistent insomnia, or worsening of the underlying condition. Prolonged underdosing may lead to increased morbidity or reduced quality of life.

Lifestyle & Prevention

  • Use medication organizers or reminders to improve adherence.
  • Educate patients on proper dosing and administration.
  • Address barriers to compliance, such as cost or access.
  • Regularly review medication regimens with healthcare providers.

When to Seek Professional Help

Seek help if symptoms of the underlying condition recur or worsen, or if dosing issues are suspected. Prompt evaluation ensures appropriate adjustments to therapy.

Tips for Medical Coders

Document the specific drug involved, dosing details, and clinical rationale for underdosing. Include notes on adherence, pharmacokinetic factors, or dosing adjustments to support code assignment. Ensure documentation aligns with clinical findings and treatment decisions.

Book a walkthrough

T42.6X6 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.